FARALLON CAPITAL MANAGEMENT LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2022$9,457,000
-21.0%
896,369
-59.3%
0.05%
-20.0%
Q2 2022$11,967,000
-50.9%
2,203,895
-17.1%
0.06%
-44.9%
Q1 2022$24,392,000
-45.5%
2,657,052
-10.3%
0.12%
-47.1%
Q4 2021$44,718,000
-36.8%
2,963,4480.0%0.22%
-32.4%
Q3 2021$70,738,0002,963,4480.33%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 474,067$11,316,00014.13%
Memorial Sloan Kettering Cancer Center 674,196$16,093,00010.03%
PFM Health Sciences, LP 4,092,309$88,176,0002.59%
CloudAlpha Capital Management Limited/Hong Kong 305,000$7,280,0002.15%
Monashee Investment Management LLC 449,377$10,727,0001.98%
Avidity Partners Management LP 2,474,067$59,056,0001.31%
Green Alpha Advisors, LLC 32,836$784,0000.54%
Tekla Capital Management LLC 699,377$15,621,0000.50%
SPHERA FUNDS MANAGEMENT LTD. 200,000$4,774,0000.40%
FARALLON CAPITAL MANAGEMENT LLC 2,963,448$70,738,0000.33%
View complete list of CARIBOU BIOSCIENCES INC shareholders